Diuretics: Mechanisms of Action

Hypertension: A Companion to Brenner and Rector's The Kidney

Volumn , Issue , 2005, Pages 638-652

  Knepper, Mark A ^a   Kleyman, Thomas ^b   Gamba, Gerardo ^c  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85135422663     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0258-5.50152-6     Document Type: Chapter

References (188)

1. Guyton AC Blood pressure control: Special role of the kidneys and body fluids. Science 1991, 252(5014):1813-1816.
2. Lifton RP, Gharavi AG, Geller DS Molecular mechanisms of human hypertension. Cell 2001, 104(4):545-556.
3. + across the nerve membrane. Biochimica et Biiophysica Acta 1960, 42:6-23.
4. McDonough AA, Farley RA Regulation of Na,K-ATPase activity. Curr Opin Nephrol Hypertens 1993, 2(5):725-734.
5. Tumlin JA, Hoban CA, Medford RM, et al. Expression of Na-K-ATPase alfa and beta subunit mRNA and protein isoforms in the rat nephron. Am J Physiol (Renal Fluid Electrolyte Physiol) 1994, 266:F240-F245.
6. Berkhin EB, Humphreys MH Regulation of renal tubular secretion of organic compounds. Kidney Int 2001, 59(1):17-30.
7. Wilcox CS New insights into diuretic use in patients with chronic renal disease. J Am Soc Nephrol 2002, 13(3):798-805.
8. Brater CD Diuretic therapy. N Engl J Med 1998, 339:387-395.
9. Lorenz JN, Schultheis PJ, Traynor T, et al. Micropuncture analysis of single-nephron function in NHE3-deficient mice. Am J Physiol 1999, 277(3 Pt 2):F447-F453.
10. Masilamani S, Knepper MA, Burg MB Urine concentration and dilution. The Kidney 2000, 595-636. Saunders, Philadelphia. B.M. Brenner (Ed.).
11. - cotransport in mouse medullary thick ascending limb. J Membrane Biol 1991, 120:83-94.
12. Schnermann J Juxtaglomerular cell complex in the regulation of renal salt excretion. Am J Physiol (Regulatory Integrative Comp Physiol) 1998, 274:R263-R279.
13. Nielsen S, Maunsbach AB, Ecelbarger CA, et al. Ultrastructural localization of Na-K-2Cl cotransporter in thick ascending limb and macula densa of rat kidney. Am J Physiol 1998, 275(6 Pt 2):F885-F893.
14. Simon DB, Karet FE, Hamdan JM, et al. Bartter's syndrome, hypokalemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 1996, 13:183-188.
15. Payne JA, Xu J-C, Haas M, et al. Primary structure, functional expression, and chromosomal localization of the bumetanide-sensitive Na-K-Cl cotransporter in human colon. J Biol Chem 1995, 270:17977-17985.
16. - cotransporter from mouse inner medullary collecting duct (mIMCD-3) cells. J Biol Chem 1994, 269:25677-25683.
17. Mount DB, Baekgard A, Hall AE, et al. Isoforms of the Na-K-2Cl transporter in murine TAL I. Molecular characterization and intrarenal localization. Am J Physiol (Renal Physiol) 1999, 276:F347-F358.
18. Plata C, Meade P, Hall AE, et al. Alternatively spliced isoform of the apical Na-K-Cl cotransporter gene encodes a furosemide sensitive Na-Cl cotransporter. Am J Physiol Renal Physiol 2001, 280:F574-F582.
19. Payne JA, Forbush B Alternatively spliced isoforms of the putative renal Na-K-Cl cotransporter are differentially distributed within the rabbit kidney. Proc Natl Acad Sci USA 1994, 91:4544-4548.
20. Igarashi P, Vanden Heuver GB, Payne JA, et al. Cloning, embryonic expression, and alternative splicing of a murine kidney-specific Na-K-Cl cotransporter. Am J Physiol (Renal Fluid Electrolyte Physiol) 1995, 269:F406-F418.
21. Gamba G Molecular biology of distal nephron sodium transport mechanisms. Kidney Int 1999, 56(4):1606-1622.
22. Burg MB Thick ascending limb of Henle's loop. Kidney Int 1982, 22:454-464.
23. Rocha AS, Kokko JP Sodium chloride and water transport in the medullary thick ascending limb of Henle. Evidence for active chloride transport. J Clin Invest 1973, 52(3):612-623.
24. Reeves WB, Molony DA, Andreoli TE Diluting power of thick limbs of Henle. III. Modulation of in vitro diluting power. Am J Physiol 1988, 255(6 Pt 2):F1145-F1154.
25. Counillon L, Pouyssegur J The expanding family of eucaryotic Na(+)/H(+) exchangers. J Biol Chem 2000, 275(1):1-4.
26. 2 production to ion transport in isolated rat thick ascending limbs and collecting tubules. Pflugers Arch 1986, 407(4):421-427.
27. Eveloff J, Bayerdorffer E, Silva P, et al. Sodium-chloride transport in the thick ascending limb of Henle's loop. Oxygen consumption studies in isolated cells. Pflugers Arch 1981, 389(3):263-270.
28. Koenig B, Ricapito S, Kinne R Chloride transport in the thick ascending limb of Henle's loop: Potassium dependence and stoichiometry of the NaCl cotransport system in plasma membrane vesicles. Pflugers Arch 1983, 399(3):173-179.
29. + channel from luminal membranes of renal red outer medulla. Biochim Biophys Acta 1985, 821(3):461-469.
30. Yang T, Huang YG, Singh I, et al. Localization of bumetanide-and thiazide-sensitive Na-K-Cl cotransporters along the rat nephron. Am J Physiol (Renal Fluid Electrolyte Physiol) 1996, 271:F931-F939.
31. - cotransporter isoforms. J Biol Chem 2002, 277(13):11004-11012.
32. Gimenez I, Isenring P, Forbush B Spatially distributed alternative splice variants of the renal Na-K-Cl cotransporter exhibit dramatically different affinities for the transported ions. J Biol Chem 2002, 277(11):8767-8770.
33. Sasaki S, Imai M Effects of vasopressin on water and NaCl transport across the in vitro perfused medullary thick ascending limb of Henle's loop of mouse, rat, and rabbit kidneys. Pflugers Arch 1980, 383(3):215-221.
34. Hall DA, Varney DM Effect of vasopressin on electrical potential difference and chloride transport in mouse medullary thick ascending limb of Henle's loop. J Clin Invest 1980, 66(4):792-802.
35. Gimenez I, Forbush B Short-term stimulation of the renal Na-K-Cl cotransporter (NKCC2) by vasopressin involves phosphorylation and membrane translocation of the protein. J Biol Chem 2003, 278(29):26946-26951.
36. Plata C, Mount DB, Rubio V, et al. Isoforms of the Na-K-2Cl cotransporter in murine TAL. II. Functional characterization and activation by cAMP. Am J Physiol (Renal Physiol) 1999, 276:F359-F366.
37. - cotransporter is mediated by regulation of cotransporter trafficking. Am J Physiol Renal Physiol 2003, 284(6):F1145-F1154.
38. Morel F, Chabardes D, Imbert-Teboul M, et al. Multiple hormonal control of adenylate cyclase in distal segments of the rat kidney. Kidney Int 1982, 11(Suppl):S55-S62.
39. 2+ transport in cortrical and medullary thick ascending limbs of mouse kidney. Pflugers Arch 1990, 417:161-167.
40. Elalouf JM, Roinel N, de Rouffignac C Effects of glucagon and PTH on the loop of Henle of rat juxtamedullary nephrons. Kidney Int 1986, 29(4):807-813.
41. Stokes JB Effect of prostaglandin E2 on chloride transport across the rabbit thick ascending limb of Henle. Selective inhibitions of the medullary portion. J Clin Invest 1979, 64(2):495-502.
42. Torikai S, Kurokawa K Effect of PGE2 on vasopressin-dependent cell cAMP in isolated single nephron segments. Am J Physiol (Renal Fluid Electrolyte Physiol) 1983, 245:F58-F66.
43. Ortiz PA, Hong NJ, Garvin JL NO decreases thick ascending limb chloride absorption by reducing Na(+)-K(+)-2Cl(-) cotransporter activity. Am J Physiol Renal Physiol 2001, 281(5):F819-F825.
44. Kim G-H, Ecelbarger CA, Mitchell C, et al. Vasopressin increases Na-K-2Cl cotransporter expression in thick ascending limb of Henle's loop. Am J Physiol (Renal Physiol) 1999, 276:F96-F103.
45. Besseghir K, Trimble ME, Stoner L Action of ADH on isolated medullary thick ascending limb of the Brattleboro rat. Am J Physiol 1986, 251(2 Pt 2):F271-F277.
46. Fernandez-Llama P, Ecelbarger CA, Ware JA, et al. Cyclooxygenase inhibitors increase Na-K-2Cl cotransporter abundance in thick ascending limb of Henle's loop. Am J Physiol 1999, 277(2 Pt 2):F219-F226.
47. Turban S, Wang XY, Knepper MA Regulation of NHE3, NKCC2 and NCC abundance in kidney during aldosterone-escape phenomenon: Role of NO. Am J Physiol Renal Physiol 2003, 10:1152.
48. Kwon TH, Nielsen J, Kim YH, et al. Regulation of sodium transporters in the thick ascending limb of rat kidney: Response to angiotensin II. Am J Physiol Renal Physiol 2003, 285(1):F152-F165.
49. Beutler KT, Masilamani S, Turban S, et al. Long-term regulation of ENaC expression in kidney by angiotensin II. Hypertension 2003, 41(5):1143-1150.
50. Brooks HL, Allred AJ, Beutler KT, et al. Targeted proteomic profiling of renal Na(+) transporter and channel abundances in angiotensin II type 1a receptor knockout mice. Hypertension 2002, 39(2 Pt 2):470-473.
51. Bartter FC, Pronove P, Gill JR, et al. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. J Am Soc Nephrol 1998, 9(3):516-528.
52. Hebert SC Bartter syndrome. Curr Opin Nephrol Hypertens 2003, 12(5):527-532.
53. Kurtz CL, Karolyi L, Seyberth HW, et al. A common NKCC2 mutation in Costa Rican Bartter's syndrome patients: Evidence for a founder effect. J Am Soc Nephrol 1997, 8(11):1706-1711.
54. Vargas-Poussou R, Feldman D, Vollmer M, et al. Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for atenatal Bartter syndrome. Am J Hum Genet 1998, 62:1332-1340.
55. Abdel A, Badawi MH, Yaeesh SA, et al. Bartter's syndrome in Arabic children: Review of 13 cases. Pediatr Int 1999, 41(3):299-303.
56. Bettinelli A, Ciarmatori S, Cesareo L, et al. Phenotypic variability in Bartter syndrome type I. Pediatr Nephrol 2000, 14(10-11):940-945.
57. + channel, ROMK. Nat Genet 1996, 14:152-156.
58. Karolyi L, Conrad M, Köckerling A, et al. Mutations in the gene encoding the inwardly-rectifying renal potassium channel, ROMK, cause the antenatal variant of Bartter syndrome: Evidence for genetic heterogeneity. International Collaborative Study Group for Bartter-like Syndromes. Hum Mol Genet 1997, 6(1):17-26.
59. Vollmer M, Koehrer M, Topaloglu R, et al. Two novel mutations of the gene for Kir 1.1 (ROMK) in neonatal Bartter syndrome. Pediatr Nephrol 1998, 12(1):69-71.
60. Feldmann D, Alessandri JL, Deschenes G Large deletion of the 5′ end of the ROMK1 gene causes antenatal Bartter syndrome. J Am Soc Nephrol 1998, 9(12):2357-2359.
61. Derst C, Wischmeyer E, Preisig-Muller R, et al. A hyper-prostaglandin E syndrome mutation in Kir1.1 (renal outer medullary potassium) channels reveals a crucial residue for channel function in Kir1.3 channels. J Biol Chem 1998, 273(37):23884-23891.
62. Schulte U, Hahn H, Konrad M, et al. pH gating of ROMK (K(ir)1.1) channels: Control by an Arg-Lys-Arg triad disrupted in antenatal Bartter syndrome. Proc Natl Acad Sci USA 1999, 96(26):15298-15303.
63. Starremans PF, Der Kemp AM, Knoers NM, et al. Functional implications of mutations in the human renal outer medullary potassium channel (ROMK2) identified in Bartter syndrome. Pflugers Arch 2002, 443(3):466-472.
64. Simon DB, Bindra RS, Mansfield TA, et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 1997, 17:171-178.
65. Konrad M, Vollmer M, Lemmink HH, et al. Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol 2000, 11(8):1449-1459.
66. Brennan TM, Landau D, Shalev H, et al. Linkage of infantile Bartter syndrome with sensorineural deafness to chromosome 1p. Am J Hum Genet 1998, 62(2):355-361.
67. Vollmer M, Jeck N, Lemmink HH, et al. Antenatal Bartter syndrome with sensorineural deafness: Refinement of the locus on chromosome 1p31. Nephrol Dial Transplant 2000, 15(7):970-974.
68. Birkenhager R, Otto E, Schurmann MJ, et al. Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet 2001, 29(3):310-314.
69. Vargas-Poussou R, Huang C, Hulin P, et al. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a bartter-like syndrome. J Am Soc Nephrol 2002, 13(9):2259-2266.
70. Watanabe S, Fukumoto S, Chang H, et al. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 2002, 360(9334):692-694.
71. Ellison DH, Velazquez H, Wright FS Thiazide-sensitive sodium chloride cotransport in early distal tubule. Am J Physiol (Renal Fluid Electrolyte Physiol) 1987, 253:F546-F554.
72. Doucet A Function and control of Na-K-ATPase in single nephron segments of the mammalian kidney. Kidney Int 1988, 34:749-760.
73. Reilly RF, Ellison DH Mammalian distal tubule: Physiology, pathophysiology, and molecular anatomy. Physiol Rev 2000, 80(1):277-313.
74. Loffing J, Kaissling B Sodium and calcium transport pathways along the mammalian distal nephron: from rabbit to human. Am J Physiol Renal Physiol 2003, 284(4):F628-F643.
75. Loffing J, Loffing-Cueni D, Valderrabano V, et al. Distribution of transcellular calcium and sodium transport pathways along mouse distal nephron. Am J Physiol Renal Physiol 2001, 281(6):F1021-F1027.
76. Obermuller N, Bernstein P, Velázquez H, et al. Expression of the thiazide-sensitive Na-Cl cotransporter in rat and human kidney. Am J Physiol (Renal Fluid Electrolyte Physiol) 1995, 269:F900-F910.
77. Campean V, Kricke J, Ellison D, et al. Localization of thiazide-sensitive Na(+)-Cl(-) cotransport and associated gene products in mouse DCT. Am J Physiol Renal Physiol 2001, 281(6):F1028-F1035.
78. Gamba G, Miyanoshita A, Lombardi M, et al. Molecular cloning, primary structure and characterization of two members of the mammalian electroneutral sodium-(potassium)-chloride cotransporter family expressed in kidney. J Biol Chem 1994, 269:17713-17722.
79. Novello FC, Sprague JM Benzothiadiazine dioxides as novel diuretics. J Am Chem Soc 1957, 79:2028-2029.
80. Kunau RT, Weller DR, Webb HL Clarification of the site of action of chlorothiazide in the rat nephron. J Clin Invest 1975, 56:407-410.
81. Stokes JB, Lee I, D'Amico M Sodium chloride absorption by the urinary bladder of the winter flounder: A thiazide-sensitive, electrically neutral transport system. J Clin Invest 1984, 74:7-16.
82. - transport by the isolated urinary bladder of the teleost, pseudopleuronectes americanus. J Exp Zool 1977, 199:383-390.
83. Renfro JL Water and ion transport by the urinary bladder of the teleost Pseudopleuronectus americanus. Am J Physiol 1975, 228:52-61.
84. 3H]metolazone. Proc Natl Acad Sci USA 1988, 85:2311-2314.
85. Tran JM, Farrell MA, Fanestil DD Effect of ions on binding of the thiazide-type diuretic metolazone to kidney membrane. Am J Physiol (Renal Fluid Electrolyte Physiol) 1990, 258:F908-F915.
86. Monroy A, Plata C, Hebert SC, Gamba G Characterization of the thiazide-sensitive Na(+)-Cl(-) cotransporter: A new model for ions and diuretics interaction. Am J Physiol Renal Physiol 2000, 279(1):F161-F169.
87. Costanzo LS Localization of diuretic action in microperfused rat distal tubules: Ca and Na transport. Am J Physiol (Renal Fluid Electrolyte Physiol) 1985, 248:F527-F535.
88. Gesek FA, Friedman PA Mechanism of calcium transport stimulated by chlorothiazide in mouse distal convoluted tubule cells. J Clin Invest 1992, 90:429-438.
89. Ray WA, Griffin MR, Downey W, Melton LJ Long-term use of thiazide diuretics and risk of hip fracture. Lancet 1989, i:687-690.
90. Wasnich R, Davis J, Ross P, Vogel J Effect of thiazide on rates of bone mineral loss: A longitudinal study. Br Med J 1990, 301:1303-1305.
91. Gamba G, Saltzberg SN, Lombardi M, et al. Primary structure and functional expression of a cDNA encoding the thiazide-sensitive, electroneutral sodium-chloride cotransporter. Proc Natl Acad Sci USA 1993, 90:2749-2753.
92. Li JH, Zuzack JS, Kau ST Winter flounder urinary bladder as a model tissue for assessing the potency of thiazide diuretics. Diuretics III: Chemistry, Pharmacology and Clinical Applications 1990, 107-110. Elsevier Science Publishing, New York. J.B. Puschett, A. Greenberg (Eds.).
93. Kyte J, Doolittle RF A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982, 157:105-132.
94. Hoover RS, Poch E, Monroy A, et al. N-glycosylation at two sites critically alters thiazide binding and activity of the rat thiazide-sensitive Na(+):Cl(-) cotransporter. J Am Soc Nephrol 2003, 14(2):271-282.
95. Kim G-H, Masilamani S, Turner R, et al. The thiazide-sensitive Na-Cl cotransporter is an aldosterone-induced protein. Proc Natl Acad Sci USA 1998, 95:14552-14557.
96. Xu J-C, Lytle C, Zhu TT, et al. Molecular cloning and functional expression of the bumetanide-sensitive Na-K-Cl cotransporter. Proc Natl Acad Sci USA 1994, 91:2201-2205.
97. Gillen CM, Brill S, Payne JA, Forbush B Molecular cloning and functional expression of the K-Cl cotransporter from rabbit, rat and human. A new member of the cation-chloride cotransporter family. J Biol Chem 1996, 271:16237-16244.
98. Payne JA, Stevenson TJ, Donaldson LF Molecular characterization of a putative K-Cl cotransporter in rat brain. A neuronal-specific isoform. J Biol Chem 1996, 271:16245-16252.
99. Caron L, Rousseau F, Gagnon E, Isenring P Cloning and functional characterization of a cation C1-cotransporter interacting protein. J Biol Chem 2000, 275:32027-32036.
100. Mount DB, Arias I, Xie Q, et al. Cloning and characterization of SLC12A9, a new member of the cation-chloride cotransporter gene family. FASEB J 2002, 16:A807.
101. Knepper MA, Brooks HL Regulation of the sodium transporters NHE3, NKCC2 and NCC in the kidney. Curr Opin Nephrol Hypertens 2001, 10(5):655-659.
102. Knepper MA Proteomics and the kidney. J Am Soc Nephrol 2002, 13(5):1398-1408.
103. Knepper MA, Masilamani S Targeted proteomics in the kidney using ensembles of antibodies. Acta Physiol Scand 2001, 173(1):11-21.
104. Hierholzer K, Wiederholt M, Stolte H [The impairment of sodium resorption in the proximal and distal convolution of adrenalectomized rats]. Pflugers Arch Gesamte Physiol Menschen Tiere 1966, 291(1):43-62.
105. Velazquez H, Bartiss A, Bernstein P, et al. Adrenal steroids stimulate thiazide-sensitive NaCl transport by rat renal distal tubules. Am J Physiol (Renal Fluid Electrolyte Physiol) 1996, 270:F211-F219.
106. Fanestil DD Steroid regulation of thiazide-sensitive transport. Semin Nephrol 1992, 12:18-23.
107. Masilamani S, Kim GH, Mitchell C, et al. Aldosterone-mediated regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney. J Clin Invest 1999, 104(7):R19-R23.
108. Masilamani S, Wang X, Kim GH, et al. Time course of renal Na-K-ATPase, NHE3, NKCC2, NCC, and ENaC abundance changes with dietary NaCl restriction. Am J Physiol Renal Physiol 2002, 283(4):F648-F657.
109. Nielsen J, Kwon TH, Masilamani S, et al. Sodium transporter abundance profiling in the kidney: Effect of spironolactone. Am J Physiol Renal Physiol 2002, 283:F923-F933.
110. - cotransporter abundance: Role of aldosterone. J Am Soc Nephrol 2001, 12(7):1335-1341.
111. Moreno G, Merino A, Mercado A, et al. Electronuetral Na-coupled cotransporter expression in the kidney during variations of NaCl and water metabolism. Hypertension 1998, 31:1002-1006.
112. Wolf K, Castrop H, Riegger GA, et al. Differential gene regulation of renal salt entry pathways by salt load in the distal nephron of the rat. Pflugers Arch 2001, 442(4):498-504.
113. Ecelbarger CA, Kim GH, Wade JB, Knepper MA Regulation of the abundance of renal sodium transporters and channels by vasopressin. Exp Neurol 2001, 171(2):227-234.
114. Ecelbarger CA, Knepper MA, Verbalis JG Increased abundance of distal sodium transporters in rat kidney during vasopressin escape. J Am Soc Nephrol 2001, 12(2):207-217.
115. Wang XY, Masilamani S, Nielsen J, et al. The renal thiazide-sensitive Na-Cl cotransporter as mediator of the aldosterone-escape phenomenon. J Clin Invest 2001, 108(2):215-222.
116. Majid DSA, Navar GL Blockade of distal nephron sodium transport attenuates pressure natriuresis in dogs. Hypertension 1994, 23:1040-1045.
117. Bickel CA, Verbalis JG, Knepper MA, et al. Increased renal Na-K-ATPase, NCC, and beta-ENaC abundance in obese Zucker rats. Am J Physiol Renal Physiol 2001, 281(4):F639-F648.
118. Ward DT, Yau SK, Mee AP, et al. Functional, molecular, and biochemical characterization of streptozotocin-induced diabetes. J Am Soc Nephrol 2001, 12(4):779-790.
119. Ecelbarger CA, Bickel CA, Verbalis JG, et al. Regulation of Na-dependent cotransporter and Na channel abundance by insulin. J Am Soc Nephrol 2002, 11:27A.
120. Verlander JM, Tran TM, Zhang L, et al. Estradiol enhances thiazide-sensitive NaCl cotransporter density in the apical plasma membrane of the distal convoluted tubule in ovariectomized rats. J Clin Invest 1998, 101:1661-1669.
121. Kim GH, Martin SW, Fernandez-Llama P, et al. Long-term regulation of renal Na-dependent cotransporters and ENaC: Response to altered acid-base intake. Am J Physiol Renal Physiol 2000, 279(3):F459-F467.
122. Amlal H, Wang Z, Soleimani M Potassium depletion down-regulates chloride-absorbing transporters in rat kidney. J Clin Invest 1998, 101:1045-1054.
123. Manning J, Beutler K, Knepper MA, et al. Upregulation of renal BSC1 and TSC in prenatally programmed hypertension. Am J Physiol Renal Physiol 2002, 283(1):F202-F206.
124. Fernandez-Llama P, Jimenez W, Bosch-Marce M, et al. Dysregulation of renal aquaporins and Na-Cl cotransporter in CCl4-induced cirrhosis. Kidney Int 2000, 58(1):216-228.
125. Kwon TH, Kiaer J, Ndez-Llama P, et al. Altered expression of Na transporters NHE-3, NaPi-II, Na-K-ATPase, BSC-1, and TSC in CRF rat kidneys. Am J Physiol 1999, 277(2 Pt 2):F257-F270.
126. Simon DB, Nelson-Williams C, Johnson-Bia M, et al. Gitelman's variant of Bartter's syndrome, inherited hypokalemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 1996, 12:24-30.
127. Mastroianni N, Bettinelli A, Bianchetti M, et al. Novel molecular variants of the Na-Cl cotransporter gene are responsible for Gitelman syndrome. Am J Hum Genet 1996, 59:1019-1026.
128. Monnens L, Bindels R, Grünfeld P Gitelman syndrome comes of age. Nephrol Dial Transplant 1998, 13:1617-1619.
129. Mastroianni N, DeFusco M, Zollo M, et al. Molecular cloning, expression pattern, and chromosomal localization of the human Na-Cl thiazide-sensitive cotransporter (SLC12A3). Genomics 1996, 35:486-493.
130. - cotransporter of the distal convoluted tubule. J Biol Chem 1998, 273:29155-29450.
131. Kunchaparty S, Palcso M, Berkman J, et al. Defective processing and expression of thiazide-sensitive Na-Cl cotransporter as a cause of Gitelman's syndrome. Am J Physiol 1999, 277(4 Pt 2):F643-F649.
132. De Jong JC, Van Der Vliet WA, van den Heuvel LP, et al. Functional expression of mutations in the human NaCl cotransporter: Evidence for impaired routing mechanisms in Gitelman's syndrome. J Am Soc Nephrol 2002, 13(6):1442-1448.
133. Cruz DN, Simon DB, Nelson-Williams C, et al. Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension 2001, 37(6):1458-1464.
134. Wilson FH, Disse-Nicodeme S, Choate KA, et al. Human hypertension caused by mutations in WNK kinases. Science 2001, 293(5532):1107-1112.
135. Mayan H, Vered I, Mouallem M, et al. Pseudohypoaldosteronism type II: Marked sensitivity to thiazides, hypercalciuria, normo-magnesemia, and low bone mineral density. J Clin Endocrinol Metab 2002, 87(7):3248-3254.
136. Simon DB, Farfel Z, Ellison D, et al. Examination of the thiazide-sensitive Na-Cl cotransporter as a candidate gene in Gordon's syndrome. J Am Soc Nephrol 1995, 6:632.
137. Vazquez N, Monroy A, Dorantes E, et al. Functional differences between flounder and rat thiazide-sensitive Na-Cl cotransporter. Am J Physiol Renal Physiol 2002, 282(4):F599-F607.
138. Yang CL, Angell J, Mitchell R, et al. WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest 2003, 111(7):1039-1045.
139. Rossier BC Negative regulators of sodium transport in the kidney: Key factors in understanding salt-sensitive hypertension?. J Clin Invest 2003, 111(7):947-950.
140. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003, 289(19):2560-2571.
141. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002, 288(23):2981-2997.
142. Psaty BM, Manolio TA, Smith NL, et al. Time trends in high blood pressure control and the use of antihypertensive medications in older adults: the Cardiovascular Health Study. Arch Intern Med 2002, 162(20):2325-2332.
143. Rossier BC, Pradervand S, Schild L, et al. Epithelial sodium channel and the control of sodium balance: Interaction between genetic and environmental factors. Annu Rev Physiol 2002, 64:877-897.
144. + channel is made of three homologous subunits. Nature 1994, 367:463-467.
145. Kosari F, Sheng S, Li J, et al. Subunit stoichiometry of the epithelial sodium channel. J Biol Chem 1998, 273(22):13469-13474.
146. Firsov D, Gautschi I, Merillat A-M, et al. The heterotetrameric architecture of the epithelial sodium channel (ENaC). EMBO J 1998, 7:344-352.
147. Snyder PM, McDonald FJ, Stokes JB, et al. Membrane topology of the amiloride-sensitive epithelial sodium channel. J Biol Chem 1994, 269(39):24379-24383.
148. Canessa CM, Merillat A-M, Rossier BC Membrane topology of the epithelial sodium channel in intact cells. Am J Physiol (Cell Physiol) 1994, 267:C1682-C1690.
149. Sheng S, Li J, McNulty KA, et al. Characterization of the selectivity filter of the epithelial sodium channel. J Biol Chem 2000, 275(12):8572-8581.
150. Snyder PM, Olson DR, Bucher DB A pore segment in DEG/ENaC Na(+) channels. J Biol Chem 1999, 274(40):28484-28490.
151. Kellenberger S, Schild L Epithelial sodium channel/degenerin family of ion channels: A variety of functions for a shared structure. Physiol Rev 2002, 82(3):735-767.
152. Vallet V, Chraibi A, Gaeggeler H-P, et al. An epithelial serine protease activates the amiloride-sensitive sodium channel. Nature 1997, 389:607-610.
153. Vuagniaux G, Vallet V, Jaeger NF, et al. Synergistic activation of ENaC by three membrane-bound channel-activating serine proteases (mCAP1, mCAP2, and mCAP3) and serum- and glucocorticoid-regulated kinase (Sgk1) in Xenopus Oocytes. J Gen Physiol 2002, 120(2):191-201.
154. Hughey RP, Mueller GM, Bruns JB, et al. Maturation of the epithelial Na+ channel involves proteolytic processing of the α- and γ-subunits. J Biol Chem 2003, 278(39):37073-37082.
155. Satlin LM, Sheng S, Woda CB, et al. Epithelial Na(+) channels are regulated by flow. Am J Physiol Renal Physiol 2001, 280(6):F1010-F1018.
156. + channel deleted in Liddle's syndrome. EMBO J 1996, 15:2371-2380.
157. + channel (ENaC) by ubiquitination. EMBO J 1997, 16:6325-6336.
158. Staub O, Abriel H, Plant P, et al. Regulation of the epithelial Na+ channel by Nedd4 and ubiquitination. Kidney Int 2000, 57(3):809-815.
159. Loffing J, Zecevic M, Feraille E, et al. Aldosterone induces rapid apical translocation of ENaC in early portion of renal collecting system: Possible role of SGK. Am J Physiol Renal Physiol 2001, 280(4):F675-F682.
160. Chen S-Y, Bhargava A, Mastroberardino L, et al. Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc Natl Acad Sci USA 1999, 96:2514-2519.
161. Debonneville C, Flores SY, Kamynina E, et al. Phosphorylation of Nedd4-2 by Sgk1 regulates epithelial Na(+) channel cell surface expression. EMBO J 2001, 20(24):7052-7059.
162. Snyder PM, Olson DR, Thomas BC Serum and glucocorticoid-regulated kinase modulates Nedd4-2-mediated inhibition of the epithelial Na+ channel. J Biol Chem 2002, 277(1):5-8.
163. Shimkets RA, Warnock DG, Bositis CM, et al. Liddle's syndrome: Heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994, 79:407-414.
164. Hansson JH, Nelson-Williams C, Suzuki H, et al. Hypertension caused by a truncated epithelial sodium channel gamma sub-unit: Genetic heterogeneity of Liddle syndrome. Nat Genet 1995, 11(1):76-82.
165. Tamura H, Schild L, Enomoto N, et al. Liddle disease caused by a missense mutation of b subunit of the epithelila sodium channel gene. J Clin Invest 1996, 97:1780-1784.
166. Su YR, Rutkowski MP, Klanke CA, et al. A novel variant of the beta-subunit of the amiloride-sensitive sodium channel in African Americans. J Am Soc Nephrol 1996, 7(12):2543-2549.
167. Geller DS, Farhi A, Pinkerton N, et al. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 2000, 289(5476):119-123.
168. Chang SS, Grunder S, Hanukoglu A, et al. Mutations in sub-unit of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet 1996, 12:248-253.
169. Geller DS, Rodriguez-Soriano J, Vallo BA, et al. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nat Genet 1998, 19(3):279-281.
170. Bull MB, Laragh JH Amiloride. A potassium-sparing natriuretic agent. Circulation 1968, 37(1):45-53.
171. Kleyman TR, Cragoe EJ The mechanism of action of amiloride. Semin Nephrol 1988, 8(3):242-248.
172. Ho K, Nichols CG, Lederer J, et al. Cloning and expression of an inwardly rectifying ATP-regulated potassium channel. Nature 1993, 362:31-38.
173. Woda CB, Bragin A, Kleyman TR, et al. Flow-dependent K+ secretion in the cortical collecting duct is mediated by a maxi-K channel. Am J Physiol Renal Physiol 2001, 280(5):F786-F793.
174. Woda CB, Miyawaki N, Ramalakshmi S, et al. Ontogeny of flow-stimulated potassium secretion in rabbit cortical collecting duct: Functional and molecular aspects. Am J Physiol Renal Physiol 2003, 285(4):F629-F639.
175. Kleyman TR, Cragoe EJ Amiloride and its analogs as tools in the study of ion transport. J Membrane Biol 1988, 105:1-21.
176. Li JH, Lindemann B Competitive blocking of epithelial sodium channels by organic cations: The relationship between macroscopic and microscopic inhibition constants. J Membr Biol 1983, 76(3):235-251.
177. Choi MJ, Fernandez PC, Patnaik A, et al. Brief report: Trimethoprim-induced hyperkalemia in a patient with AIDS. N Engl J Med 1993, 328(10):703-706.
178. Schild L, Schneeberger E, Gautschi I, et al. Identification of amino acid residues in the a, b and g subunits of the epithelial sodium channel (ENaC) involved in amiloride block and ion permeation. J Gen Physiol 1997, 109:15-26.
179. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999, 341(10):709-717.
180. Brown NJ Eplerenone: Cardiovascular protection. Circulation 2003, 107(19):2512-2518.
181. Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003, 348(14):1309-1321.
182. Krishna GG, Shulman MD, Narins RG Clinical use of the potassium-sparing diuretics. Semin Nephrol 1988, 8(4):354-364.
183. Krishna GG, Kapoor SC Potassium depletion exacerbates essential hypertension. Ann Intern Med 1991, 115(2):77-83.
184. Freis ED The efficacy and safety of diuretics in treating hypertension. Ann Intern Med 1995, 122:223-226.
185. Prichard BN, Owens CW, Woolf AS Adverse reactions to diuretics. Eur Heart J 1992, 13(Suppl G):96-103.
186. Helderman JH, Elahi D, Andersen DK, et al. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes 1983, 32(2):106-111.
187. Ryan MP Magnesium and potassium-sparing diuretics. Magnesium 1986, 5(5-6):282-292.
188. + homeostasis and hypertension. Endocr Rev 2002, 23(2):258-275.